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Abstract 
POP1 is a large protein common to the RNase-MRP and RNase-P (RMRP) endoribonucleoprotein 
complexes. Although its precise function is unknown, it appears to participate in the assembly or 
stability of both complexes. Numerous RMRP mutations have been reported in individuals with 
cartilage hair hypoplasia (CHH) but, to date, only three POP1 mutations have been described in two 
families with features similar to anauxetic dysplasia (AD). We present two further individuals, one 
with severe short stature and a relatively mild skeletal dysplasia and another in whom AD was 
suspected. Biallelic POP1 mutations were identified in both. A missense mutation and a novel single 
base deletion were detected in proband 1, p.[Pro582Ser]:[Glu870fs*5]. Markedly reduced abundance 
of RMRP and elevated levels of pre5.8s rRNA was observed. In proband 2, a homozygous novel 
POP1 mutation was identified, p.[(Asp511Tyr)];[(Asp511Tyr)]. These two individuals demonstrate 
the phenotypic extremes in the clinical presentation of POP1-dysplasias. Although CHH and other 
skeletal dysplasias caused by mutations in RMRP or POP1 are commonly cited as ribosomal 
biogenesis disorders, recent studies question this assumption. We discuss the past and present 
knowledge about the function of the RMRP complex in skeletal development.
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Introduction 
In the 2015 nosology of skeletal dysplasias (SD), 436 different dysplasias were classified into 
42 groups, associated with alterations in >364 genes (1). Discovery of new genes has considerably 
increased with the implementation of whole exome/genome sequencing and at the same time, Next 
generation sequencing (NGS) based diagnostics has become a central tool in improving mutation 
detection and expanding the phenotypic spectrum of known disorders.  
The RNAse for mitochondrial RNA processing (RMRP) endoribonuclease complex, 
composed of a RNA subunit and 10 different proteins, has been identified in virtually all eukaryotes 
(2-6). It is essential for cell viability and appears to have evolved from the RNase-P complex to 
perform specialized functions (5,7-12). One of the proteins shared by both complexes is the Processing 
of Precursor 1 (POP1) homolog ribonuclease P/MRP subunit, a large protein that seems to stabilize 
RNase-P and RMRP complexes (14). Care must be taken in order to avoid confusion with the PYRIN 
Domain-only Protein, also called POP1.  
The RNAse for mitochondrial RNA processing gene (RMRP, MIM 157660), encoding the 
untranslated RNA subunit was the first non-coding nuclear RNA associated with human disease (15). 
Currently, we know that alterations in RMRP are related to several autosomal recessive SDs with 
varying severity: mild metaphyseal dysplasia without hypotrichosis (MIM 250460); moderate 
cartilage-hair hypoplasia (CHH, MIM 250250), and severe anauxetic dysplasia (AD, MIM 
607095)(16-19). 
CHH is a metaphyseal dysplasia in which the limbs and ribs are mostly affected. There is 
thickening and shortening of the long bones, with wide, irregular, and partially sclerotic metaphyseal 
borders of the growth plates. Skeletal alterations are present at birth and are distinguished from other 
metaphyseal dysplasias by more severe affectation of the knee compared to the proximal femur. The 
spine and skull are generally conserved (18,20,21). AD is a severe spondyloepimetaphyseal dysplasia 
with severe short stature of prenatal onset, very short adult height (less than 1m), hypodontia, midface 
hypoplasia and mild intellectual disability. Vertebrae are ovoid with concave dorsal surfaces in the 
lumbar region and show delayed bone maturation. Femoral heads and necks are hypoplastic, as well as 
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the iliac bodies. Long bones have irregular mineralization of the metaphyses. The first and fifth 
metacarpals are short and wide with small, late-ossifying epiphyses and bullet-shaped middle 
phalanges. A large reduction in the number of chondrocytes in the resting and proliferating zones, with 
diminished columnisation of the hypertrophic zone has also been observed (19,22,23).  
In 2011, two sisters with a SD similar to AD were described (24). Exome analysis revealed 
two compound heterozygous POP1 mutations, a gene previously not associated with any disease. 
More recently, a homozygous POP1 mutation was identified in another similarly affected individual 
and the authors suggested that they should be classified as POP1-associated skeletal phenotype AD 
type 2 (25). 
We present two index cases, one with an unknown SD and another in whom AD was 
suspected, in whom biallelic POP1 mutations were identified. These two probands demonstrate the 
extremes in clinical presentation of POP1 mutations, and we then compare them to those reported 
previously. We also review the available literature about the role of POP1 and its relationship with 
disease. 
 
Clinical cases  
Proband 1 
Female of Moroccan origin, born to healthy, non-consanguineous parents. Father’s height was 
180 cm (0.4 SDS) and mother’s 164 cm (0.1 SDS). Pregnancy was without complications and the 
child was delivered at 37.5 weeks by caesarean section, weight 2535g (-2.3 SDS), body length (BL) 45 
cm (-3.1 SDS) and head circumference (HC) 34 cm (-1.4 SDS). Short limbs were noted at birth. 
Karyotype, biochemical and hormonal studies were normal.  
At 4.6 years of age, she weighed 11.8 kg (-2.47 SDS), height 84.4 cm (-5.57 SDS) and HC 
51.8cm (1.7 SDS)(Fig. 2). On physical examination, she had relative macrocephaly, short neck, broad 
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chest, hyperlordosis, brachydactyly, cubitus valgus with difficulties at extension, and prominent heels 
(Fig. 2). Psychomotor development was normal.  
Radiographic analysis showed mild irregularity of the vertebral end plates with posterior 
scalloping of the lower lumbar vertebral bodies, delayed ossification, hypoplastic femoral necks and in 
valgus position, slightly widened iliac angle, irregular metaphyses of distal femur and proximal and 
distal tibiae, irregular metaphyses and cone-shaped epiphyses of all proximal and middle phalanges, 
and bullet-shaped middle phalanges (Fig. 1A-J). Clinical and radiological data are summarized in 
Table S1. 
 
Proband 2 
Male of Senegalese origin born to healthy parents. Although consanguinity was denied, both 
parents were from the same village. Father’s height 178 cm (0.09 SDS), and mother’s 165 cm (0.15 
SDS). Intrauterine growth retardation was noted on ultrasound performed at 24-gestational weeks. He 
was born at 38 weeks, weight 2210g (-2.32 SDS), BL 38 cm (-6.83 SDS) and HC 31 cm (-1.9 SDS).  
He was first seen at 2 years old; height 59.5 cm (-10.18 SDS), weight 6200g (-4.73 SDS) and 
HC 46 cm (-2.73 SDS). He was able to walk with help. Clinical exam revealed major deformities of 
upper and lower limbs. Radiological analysis (Fig. 1K-Q) showed severely delayed bone age. He had 
tall vertebral bodies with posterior scalloping of the lower lumbar vertebral bodies. The pelvis showed 
narrow iliac wings with mild flaring of the acetabula. He had short, broad humeri with irregular 
proximal metaphyses, bowing of the ulna, short femoral necks, coxa vara with vertical orientation of 
the proximal femoral physes and irregularity and sclerosis of the femoral and tibial metaphyses. 
Middle phalanges were bullet-shaped. A new radiological analysis at age 7 (Fig. 1O-Q), revealed 
thoracolumbar scoliosis, flared metaphyses with irregular margins in the long bones, cupped distal 
tibial metaphyses, and chevron deformity of distal femoral epiphyses with premature fusion of the 
growth plate.  
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At six years, his height was 62.5 cm (-10.99 SDS), weight 7200g (-4 SDS) and HC 47.5 cm (-
3.51 SDS)(Fig. 2). Physical examination revealed sparse and apparently hypopigmented hair, 
hypodontia, cubitus valgus with flexion contractures of the elbows. His hands were smaller when 
compared to the limbs, with pointed fingers and small, dysplastic nails. He had hip flexion deformity, 
kyphosis and prominent heels (Fig. 2, S1). He has cognitive developmental delay. Brain magnetic 
resonance imaging showed hyperintensity of the subcortical and periventricular white matter 
associated with non-specific subcortical bitemporal edema (Fig. S2). There were no lactate peaks at 
spectroscopy. Deficiency of complex I of the mitochondrial respiratory chain was also found in 
fibroblasts, without an assembly abnormality on the BN-PAGE. But, no features of mitochondrial 
disease were found including normal hearing and eye-survey and metabolic screening. A clinical 
diagnosis of CHH/AD was suspected, based on his extreme short stature, lumbar hyperlordosis and 
kyphoscoliosis, severe long-bone shortening with irregular metaphyses and deformed epiphyses, and 
brachydactyly with delayed carpal ossification. The absence of RMRP mutations, led to POP1 direct 
sequencing.  
 
Materials & Methods 
All participants provided informed consent and ethical approval was obtained from the 
respective institutions. DNA was extracted from all participants and RNA was extracted from proband 
1 and parents. 
Proband 1, with an unknown SD, was analyzed with a custom-designed targeted NGS panel 
(SkeletalSeq.V3, 315 SD genes) using SeqCap EZ technology (Roche Nimblegen) and sequenced on a 
MiSeq (Illumina). In house bioinformatic analysis was performed using: Bowtie2 v2.0; Picard-tools 
1.27: Samtools v0.1.19-44428cd; Bedtools v2.16.1; Isis 2.4.60.8, BWA 0.6.1-r104-tpx, Genome 
Analysis TK v2.6-5, SnpE 3.5e, dbNSFP v2.7, dbSNP v137, ClinVar and human genomic reference 
sequence hg19. POP1 direct sequencing was undertaken for proband 2 and his parents.  
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Variants were evaluated with the help of Alamut V2.8 and CADD V1.3 
(http://cadd.gs.washington.edu/), conservation using GerpN and population databases were consulted 
for frequency data: Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org), NHLBI-
GO Exome Sequencing Project (ESP; https://esp.gs.washington.edu/drupal/) and Kaviar 
(http://db.systemsbiology.net/kaviar). 
To determine the functional impact of the mutated alleles, we measured relative abundance of 
RMRP and unprocessed pre-5.8S rRNA compared to endogenous GAPDH in proband 1, her 
unaffected parents, and age- and sex-matched controls, as previously described (24). All reactions 
were undertaken in triplicate and three biological replicas were performed. 
 
Results 
Compound heterozygous and homozygous POP1 mutations were identified in probands 1 and 
2, respectively (Table S2). In proband 1, a missense mutation in exon 13 and a one base deletion in 
exon 16 were detected, c.[1744C>T];[2607delC]; p.[Pro582Ser];[Glu870fs*5] (Fig. 3). Both variants 
are absent from population databases. The missense variant has been recently reported in 
homozygosity in an individual from Morrocco (25). It affects a highly conserved amino acid and in 
silico pathogenicity predictions classify the variant as highly deleterious. This mutation was inherited 
from the mother. The paternally inherited single base deletion in exon 16 is predicted to result in a 
premature stop codon.  
Gene expression assays demonstrated that patient 1 had a markedly reduced abundance of 
RMRP and elevated levels of pre5.8S rRNA when compared to his unaffected parents and age- and 
sex-matched controls (Fig. 3).  
A homozygous mutation was found in exon 11 of POP1 in patient 2: 
c.[1531G>T];[1531G>T];  p.[(Asp511Tyr)];[(Asp511Tyr)]) and in heterozygosity in the unaffected 
parents (Fig. 3). This missense mutation affects a highly conserved amino acid, absent from the 
population databases and is classified as pathogenic by all in silico predictors.  
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Discussion 
In this work, biallelic POP1 mutations have been identified in two children with a SD with 
different degrees of severity. Proband 1 is a compound heterozygote for a missense and a frameshift 
mutation. Interestingly, the p.Pro582Ser mutation has been recently reported in homozygosity in a 
Moroccan individual with AD-like features (25). As proband 1 is also of Moroccan origin, the two 
individuals probably share a common ancestor. However, the clinical and radiological data for 
proband 1 were less severe thus, we did not suspect AD. However, retrospectively, her skeletal 
findings are very similar, although milder, to the three previously described cases (24-25).  
In contrast, AD was directly suspected in proband 2 but, when no pathogenic mutations were 
found in RMRP and given the previous report of POP1 mutations in AD type 2, POP1 was considered 
as a good candidate gene. Indeed, direct sequencing identified a homozygous POP1 mutation. This 
patient has clinical features common to CHH such as hypodontia, sparse and hypopigmented hair, but 
also additional features, such as cognitive delay, forearm and hand abnormalities, and brain 
abnormalities, observed by MRI.  
Thus, to date, five different POP1 mutations have been reported in five individuals from four 
families (this study, 24-25)(Fig. 3). Two mutations, a missense and a nonsense, are located in exon 11, 
codons 511 and 513, in a highly conserved region between the POP1 and POPLD domains. The 
nonsense mutation is predicted to result in a mutant protein lacking the POPLD domain. Another two 
missense mutations are located in exon 13, encoding Pro582 and Gly583 in the POPLD domain. 
Interestingly, the proximal Ser584 is one of four amino acids shown to be phosphorylated (26). The 
most C-terminal mutation is located in the last exon, exon 16, and results in the premature truncation 
of the protein which is unlikely to be exposed to nonsense mediated decay. Although this mutant 
protein contains both POP1 domains, its loss of function may be due to a conformational defect. It is 
noteworthy that, although proband 2 has a missense mutation located very close to the previously 
reported nonsense variant (24), his phenotype appears to be much more severe.  
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We compared available clinical and radiological data of the three previous individuals with the 
two cases described in this study (Table S1). Intrauterine growth restriction was noted in 3/5 cases, all 
going on to have shortened BL. Severe postnatal growth retardation was identified in all cases. 
Involvement of the epiphysis and metaphysis of the long bones and various vertebral bodies 
abnormalities were described in all individuals (Table S1), bullet-shaped phalanges were identified in 
four individuals, involvement of the pelvic bones was noted in three cases, and two had coxa vara. 
Finally, in all patients except patient 1, the initial suspected diagnosis was AD. Joint laxity, described 
in some patients with AD, was only observed in one patient whilst, probands 1 and 2 had limited 
extension of the elbows.  
Attempts to characterize the function of yeast Pop1 in vitro have not been successful, mainly 
due to its insolubility (27). Mutagenizing four evolutionarily conserved Pop1 regions and examining 
the effects of these mutations on the function and biogenesis of RNase-P and MRP in vivo showed that 
many affect processing of one or more of the precursors of tRNA and the 5.8S rRNA in yeast, 
suggesting that the mutated positions have similar roles in the functions of the RNase-P/MRP (4,7,27-
30). Pop1 mutations have also been shown to be implicated in holoenzyme assembly, leading to 
destabilization of the RNA component, producing substrate processing defects in both the RNase-
P/MRP (27,30). These studies explain why CHH and other SDs caused by mutations in the RNA of 
RMRP or POP1 are commonly cited as diseases with alterations in ribosomal biogenesis (reviewed in 
ref 21). However, recent studies have laid doubt on these assumptions. When POP1 was depleted in 
HeLa cells using interference RNA (RNAi), the levels of pre-rRNA intermediate or in the rate 
5.8SS/5.8SL were not significantly altered (31). Furthermore, mature rRNA levels were not 
significantly affected by the depletion of POP1, and, most importantly, there was no change in 5.8S 
species (31-32). However, increased levels of 5.8S rRNA precursor have been found in patient 1, the 
two previously reported siblings with POP1 mutations (24), and in CHH patients (19). Thus, further 
studies will be required to clarify the function of POP1. 
In proband 2, the deficiency of complex I of the respiratory chain was an unexpected finding. 
The RNase-MRP complex was originally identified in murine cells by its ability to process an RNA 
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transcript complementary to the light strand to generate RNA primers for the heavy-strand DNA 
replication in vitro. Currently, there is discussion about whether RMRP exerts some function in the 
human mitochondria. It has been shown that mitochondria of a HeLa cell contain 6-15 RMRP RNA 
molecules and not more than 175 molecules of RNase P RNA, amounts too low to be functionally 
relevant (33-34). This would suggest that RNase-P/MRP complexes reside exclusively in the nuclear 
compartment, and the mitochondrial activities are associated with other complexes (35-36). 
Mitochondrial disease features, such as complex I deficiency, have not been previously 
reported in individuals with POP1 or RMRP mutations. This may be a coincidental finding and due to 
a mutation in another gene. Alternatively, the complex 1 deficiency could be related to the 
homozygous POP1 mutation and be one of the first reports of an association between SD and 
mitochondrial impairment. However, none of the known functions of POP1 can explain this 
observation, thus it will be interesting to investigate if there is a functional connection. Recently 
another protein, MAGMAS, involved in the importing of pre-proteins into the mitochondria and 
essential for cell growth and development, has been linked with a severe spondylodysplastic dysplasia 
(37). 
Other functions of the RMRP complex may provide an insight into the molecular pathology of 
RMRP- and POP1-associated dysplasias. It is known that mRNA levels of cyclin B2 are regulated by 
RMRP, and that degradation of cyclin B can regulate the cell cycle (38-39). 
RMRP/TERT complexes have also been localized, mainly to the nucleus of cells expressing 
telomerase (40-41). RNA RMRP-TERT complexes produce double-stranded RNA that are processed 
by Dicer to produce siRNAs, which may target genes implicated in skeletal developmental, hair 
development, and hematopoietic differentiation among others; suggesting that the altered production 
of siRNA may be the primary pathogenic mechanism in CHH. However, it is the RNA subunit of 
RNase-MRP that interacts with the complex TERT and not the protein subunits of the complex, so this 
link may not extend to POP1 associated dysplasias.  
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Increased viperin expression has also been observed in patients with CHH and in vivo when 
RMRP and its complex subunits, including POP1, are knocked down by RNAi (31,42). Viperin 
mRNA is a substrate for cleavage activity of the RNase-MRP complex. Recently, viperin expression 
has been observed in murine chondrocytes during several developmental stages, and may act as a 
chondrogenic regulator (42). 
In summary, POP1 mutations have been identified in two individuals with SDs of different 
severity, expanding the phenotypic spectrum of POP1-associated AD type 2. POP1 mutations should 
be considered in AD patients without RMRP mutations. Our description of a milder phenotype may 
lead to the identification of additional cases. Finally, further research into the functions of the RMRP 
complex and POP1 is needed, to define the molecular mechanism of these SDs. 
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Figure legends 
Figure 1: Radiological analysis of probands 1 and 2. Radiographs of proband 1 at 4.6y (A-J) and 
proband 2 at age 2 (K-N) and 7 y (O-Q). A: Macrocephaly, B. Narrow pedicles, C. Mild irregularity of 
vertebral end plates, D. Narrow pedicles lower thoracic and upper lumbar spine, E. Posterior 
scalloping lower lumbar vertebral bodies, F. Significantly delayed bone age (chronological age = 4.6 
years, female std dev = 8m, bone age = 2yrs). Cupped, sclerotic, irregular metaphyses of 2
nd
 to 4
th
 
metacarpals and all proximal and middle phalanges, cone-shaped epiphyses of proximal and middle 
phalanges, similar to that in CHH, bullet-shaped middle phalanges, ivory epiphysis proximal 
phalanges 5
th
 fingers and mild proximal pointing of base of 2
nd
 to 5
th
 metacarpals, G. & H. Patchy 
linear sclerosis of the proximal humeral metaphyses, I. Coxa valga. Irregularity and sclerosis of distal 
femoral metaphyses, J. Irregularity and sclerosis of distal femoral, proximal tibial and distal tibial 
metaphyses, K. Tall vertebral bodies and posterior scalloping of lower lumbar vertebral bodies, L. 
Bowed femur. Irregularity and sclerosis of metaphyses of femur and tibia, M. Short, broad humerus 
with irregular proximal metaphysis. Bowing of the ulna. Bullet-shaped middle phalanges. Severely 
delayed bone age with no ossified epiphyses of the hand and wrist (chronological age = 2 yrs, male std 
dev = 4m, bone age = birth), N. Narrow iliac wings with mild flaring of the acetabula. Short femoral 
necks, coxa vara with vertical orientation of femoral physes and medial fragmentation of the proximal 
femoral metaphyses, O. Bilateral coxa vara deformity. Short, broad and bowed femora. Flared 
metaphyses with irregular margins. Cupped distal tibial metaphyses. Chevron deformity of distal 
femoral epiphyses with premature fusion of the growth plates, P-Q. Normal segmentation. Tall 
vertebral bodies with posterior scalloping of lower thoracic and lumbar vertebral bodies. 
Thoracolumbar scoliosis centered at T12. Relatively broad ribs. 
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Figure 2: Clinical photographs and growth curve of the probands. Proband 1 at 4.6 years of age (A, C, 
E and G): Female individual with relative macrocephaly, short neck, broad chest, hyperlordosis, 
brachydactyly with stubby fingers, cubitus valgus with difficulties at extension, and prominent heels. 
Proband 2 at age 5 (B, D) and 7 years of age (F, H): he has sparse and apparently hypopigmented hair. 
His hands were smaller when compared to his limbs and he had deep palmar creases. He had pointed 
fingers and his thumbs seemed abnormally located. He also had prominent thorax, hip flexion 
deformity, kyphosis and prominent heels. The growth curves of proband 1 (I) and proband 2 (J) 
showing marked growth delay, more severely in proband 2 compared to proband 1.  
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Figure 3: Genetic characterization of the POP1 mutations detected in probands 1 and 2. A,B,C: 
Chromatograms of the POP1 mutations detected in probands 1 (A,B) and 2 (C). Proband 1 was a 
compound heterozygote for two POP1 mutations: c.1744C>T, inherited from the mother, and a single 
base deletion from his father, c.2607delC. Proband 2 was homozygous for the c.1531G>T mutation. 
D: Expression levels of RMRP and pre-5.8S rRNA in proband 1 (P), his mother (M) and father (F) and 
three unrelated age and sex-matched controls (C1, C2, C3). E: Schematic diagram of POP1 protein 
structure showing the localization of the mutations identified in probands 1 and 2 (green arrows) and 
those previously described mutations, blue arrows (p.(Arg513*);(Gly583Glu), ref 24), red arrows 
(p.(Pro582Ser);(Pro582Ser), ref 25). Orange box: POP1 domain; blue box: POPLD domain. Data has 
been deposited in PhenomeCentral. 
 
This article is protected by copyright. All rights reserved.
